HomeAI · summaries
Storia in 2 fonti
Corneal endothelial cell therapy earns regenerative medicine advanced therapy designation
The FDA granted regenerative medicine advanced therapy designation to EO2002 for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release from Emmecell.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Corneal endothelial cell therapy earns regenerative medicine advanced therapy designation
The FDA granted regenerative medicine advanced therapy designation to EO2002 for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press…
- ·
morningstar.com
Emmecell Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EO2002 for the Treatment of Corneal Endothelial Disease
Emmecell Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EO2002 for the Treatment of Corneal Endothelial DiseaseRMAT designation recognizes the…